Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06963801 · ClinicalTrials.gov registry record · NA

DBT-P Treatment Study

A NA study of Emotion Dysregulation, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06963801: Recruiting NA study of Emotion Dysregulation, sponsored by Duke University.

NCT06963801 is a NA study of Emotion Dysregulation that is actively recruiting participants, run by Duke University. The registered enrollment target is 100 participants, above the 85-participant average among 3 other Emotion Dysregulation trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06963801, a NA study of Emotion Dysregulation, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to find out if improving emotion regulation skills use during pregnancy reduces maternal stress and improves heart rate. The main questions it aims to answer are: * Does improving emotion regulation skills during pregnancy reduce stress and improve the ability to cope? * How is a participant's heart rate affected by their ability to control their emotions during pregnancy? Researchers will test the hypothesis that dialectical behavior therapy skills groups (DBT-P) will improve emotion regulation skills use as well as heart rate. Participants will: * Visit the clinic for 3 sessions at the beginning, middle and end of their pregnancy. * Compete surveys and interviews asking about their thoughts, feelings and how they cope with emotions. * Have their heart rate taken. * If assigned to the investigational group, they will complete weekly remote emotion regulation skills groups for 10 weeks and complete daily diary cards that ask about mood and any thoughts of self-harm. * Optional Element: Complete a 20-30min infant neurobehavior exam (NNNS exam) after delivery.

Primary Outcome

The DERS is a 36-item measure scored on a 5-point Likert Scale. DERS scores range from 36-180 and enrollment in this study requires a baseline total DERS score of ≥88 which indicate greater difficulties in emotion regulation.

Conditions Studied

Interventions

  • BEHAVIORAL Moms2B
  • BEHAVIORAL DBT-P

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-06
Est. Completion 2026-10-19
Phase NA
Duke University

1,725 total trials

What NCT06963801 shows while recruiting

NCT06963801 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 3 other Emotion Dysregulation trials with a reported enrollment target (18% higher).

The record links to 1 condition, with Emotion Dysregulation appearing as the primary indexed condition, and to 2 interventions - of which Moms2B is the first listed.

NCT06963801 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06963801 about?

NCT06963801 is a clinical study titled "DBT-P Treatment Study". The goal of this study is to find out if improving emotion regulation skills use during pregnancy reduces maternal stress and improves heart rate. The main questions it aims to answer are: * Does improving emotion regulation skills during pregnancy reduce stress and improve the ability to cope? * ...

What is the current status of trial NCT06963801?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-06. Estimated completion is 2026-10-19.

What conditions does trial NCT06963801 study?

This clinical trial studies the following conditions: Emotion Dysregulation.

What interventions are being tested in trial NCT06963801?

The interventions under investigation include: Moms2B (BEHAVIORAL), DBT-P (BEHAVIORAL).

Who is sponsoring clinical trial NCT06963801?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06963801 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotion Dysregulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06963801, the US trial registry maintained by the National Library of Medicine. NCT06963801 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.